1Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol, 1998,31:1506-1510.
2Wang XL,Sim AS, Badenhop RF, et al. A smokingg-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med, 1996,241- 45.
3Zancbi A,Wantman M,Moczulski D,et al. Genetic susceptibility to diabetic nepbropatby in IDDM is related to polymorpbism in the endothelial nitric oxide syntbase (eNOS) gene. Diabetes, 1999,48 (suppl) :A52.
4Weekers L, Hadjadj S, Belloum R, et al. Lack of contribution of two endothelial nitric oxide synthase(eNOS) gene polymorphism to diabetic nephropathy in type ldiabetes. Diabetologia, 1999, 42 (suppl) :A266.
5Odaware M, Sasaki K, Tachi Y, et al. Endothelial nltric oxide synthase gene polymorphism and coronary heart disease in Japanese NIDDM. Diabetologia, 1998,41:365.
6Neugebauer S,Baba T,Watanabe T,et al. Association of the nitric oxide syntbdSe gene polymorpbism with an increased risk for progression to diabetic nepbropatby in type 2 diabetes. Diabetes, 2000,49:500-503.
7Ferguson MWJ, Herrick SE, Spencer MJ, et al. The histology of diabetic foot ulcers. Diabetes Med, 1996,13 :S30- 33.
8Veves A, Akbari CM. Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes, 1998,47:457-463.
9Jude EB, Boulton AJM, Ferguson MWJ, et al. The role of nitric oxide syntbase isoforms and arginase in the patbogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor bete 1. Diabetologia, 1999,42 : 748- 757.
